Boston Scientific to launch Promus stent system

By Lisa Kerner

Charlotte, N.C., Sept. 1 - Boston Scientific Corp. said it plans an international launch of its new Promus Everolimus-eluting coronary stent system.

The medical-device company expects the Promus stent to be available in the United States sometime in 2008, pending Food and Drug Administration approval.

Boston Scientific's drug-eluting stent program is based on the Taxus stent, introduced in Europe in 2003. The second-generation Taxus Liberte stent, launched internationally in 2005, could reach the U.S. market in early 2007.

Three million Taxus stents have been implanted in patients worldwide, according to the Natick, Mass.-based Boston Scientific.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.